Free Trial

Owens & Minor, Inc. (NYSE:OMI) Major Shareholder Buys $1,881,600.00 in Stock

Owens & Minor logo with Medical background

Owens & Minor, Inc. (NYSE:OMI - Get Free Report) major shareholder Coliseum Capital Management, L purchased 240,000 shares of the company's stock in a transaction dated Monday, April 7th. The shares were acquired at an average price of $7.84 per share, with a total value of $1,881,600.00. Following the transaction, the insider now owns 11,152,955 shares in the company, valued at approximately $87,439,167.20. The trade was a 2.20 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Major shareholders that own at least 10% of a company's stock are required to disclose their sales and purchases with the SEC.

Coliseum Capital Management, L also recently made the following trade(s):

  • On Wednesday, April 9th, Coliseum Capital Management, L acquired 225,000 shares of Owens & Minor stock. The shares were bought at an average price of $7.39 per share, for a total transaction of $1,662,750.00.
  • On Thursday, April 3rd, Coliseum Capital Management, L bought 160,000 shares of Owens & Minor stock. The stock was bought at an average price of $8.53 per share, with a total value of $1,364,800.00.
  • On Monday, March 3rd, Coliseum Capital Management, L purchased 354,901 shares of Owens & Minor stock. The shares were purchased at an average price of $9.19 per share, for a total transaction of $3,261,540.19.
  • On Friday, February 28th, Coliseum Capital Management, L acquired 1,738,511 shares of Owens & Minor stock. The shares were purchased at an average price of $9.39 per share, for a total transaction of $16,324,618.29.

Owens & Minor Trading Down 1.4 %

OMI traded down $0.10 during trading on Friday, hitting $6.90. 1,491,192 shares of the stock traded hands, compared to its average volume of 1,079,969. The firm has a market capitalization of $533.00 million, a P/E ratio of -10.62, a price-to-earnings-growth ratio of 0.20 and a beta of 1.02. Owens & Minor, Inc. has a 12-month low of $6.07 and a 12-month high of $26.05. The company has a debt-to-equity ratio of 2.11, a current ratio of 1.09 and a quick ratio of 0.45. The firm has a 50-day moving average of $8.44 and a 200 day moving average of $11.79.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping analysts' consensus estimates of $0.53 by $0.02. Owens & Minor had a negative net margin of 0.46% and a positive return on equity of 14.60%. The company had revenue of $2.70 billion during the quarter, compared to analyst estimates of $2.68 billion. During the same period in the prior year, the business posted $0.69 earnings per share. Owens & Minor's revenue for the quarter was up 1.5% on a year-over-year basis. Equities research analysts anticipate that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor declared that its Board of Directors has initiated a share buyback plan on Friday, February 28th that authorizes the company to buyback $100.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 13.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on the company. JPMorgan Chase & Co. cut their target price on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a research note on Monday, March 10th. UBS Group cut their price objective on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a research note on Thursday, February 13th. Finally, Robert W. Baird lifted their target price on shares of Owens & Minor from $10.00 to $11.00 and gave the stock a "neutral" rating in a research report on Monday, March 3rd. Two equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $13.75.

View Our Latest Stock Report on Owens & Minor

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Sterling Capital Management LLC increased its position in shares of Owens & Minor by 758.3% during the fourth quarter. Sterling Capital Management LLC now owns 2,060 shares of the company's stock valued at $27,000 after buying an additional 1,820 shares during the period. Versant Capital Management Inc grew its holdings in shares of Owens & Minor by 537.6% during the 1st quarter. Versant Capital Management Inc now owns 3,201 shares of the company's stock worth $29,000 after acquiring an additional 2,699 shares during the period. Parallel Advisors LLC raised its position in shares of Owens & Minor by 1,387.0% in the 1st quarter. Parallel Advisors LLC now owns 3,316 shares of the company's stock worth $30,000 after acquiring an additional 3,093 shares in the last quarter. Blue Trust Inc. lifted its stake in shares of Owens & Minor by 57.4% in the 4th quarter. Blue Trust Inc. now owns 4,387 shares of the company's stock valued at $57,000 after purchasing an additional 1,600 shares during the period. Finally, KBC Group NV boosted its position in shares of Owens & Minor by 98.2% during the fourth quarter. KBC Group NV now owns 4,434 shares of the company's stock valued at $58,000 after purchasing an additional 2,197 shares in the last quarter. 98.04% of the stock is currently owned by institutional investors.

About Owens & Minor

(Get Free Report)

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.

Featured Articles

Insider Buying and Selling by Quarter for Owens & Minor (NYSE:OMI)

Should You Invest $1,000 in Owens & Minor Right Now?

Before you consider Owens & Minor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.

While Owens & Minor currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Buy Early: 3 Tech Trends With Millionaire-Making Potential
5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines